Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.

Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Sept 1997

Logan T F, Gooding W E, Whiteside T L, Ernstoff M S, Kaplan S S, Miketic L, Vlock D R, Tompkins C, Wood D L, Nadler P I, Kirkwood J M

Abstract excerpt

During a phase I study of recombinant human tumor necrosis factor (TNF) in cancer patients, serial immune studies were performed and analyzed for effects of TNF. The TNF (specific activity 9.6 x 10(6) U/mg protein, < 5.0 endotoxin units/mg protein) was given over 2 h intravenously on days 1, 8-12, 29-33, 50-54, and 71-75 at doses of 40, 80, 160, 200, and 240 micrograms/m2. Immunologic testing was performed before...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to TNF gene
Share to Interferon-gamma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interleukin-2

Share to Multivariate Analysis

Share to Neoplasms

Share to Phenotype

Share to T-Lymphocyte Subsets

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 9336746
DOI: 10.1097/00002371-199709000-00008

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.PMID 9336746Read ↗

A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo.Semantic proximity Read ↗

Resistance to tumor necrosis factor induced apoptosis in vitro correlates with high metastatic capacity of cells in vivo.Semantic proximity Read ↗

In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.Semantic proximity Read ↗

Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants.Semantic proximity Read ↗

Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.Semantic proximity Read ↗

Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes.Semantic proximity Read ↗

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.Semantic proximity Read ↗

The effect of cytokines on cultured mononuclear cells from patients with B cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.Semantic proximity Read ↗

Augmentation of specific tumor killing activity by tumor-infiltrating lymphocytes (TIL) in the presence of TNF-SAM2.Semantic proximity Read ↗

Retrovirus-mediated gene transfer of the cytokine genes interleukin-1beta and tumor necrosis factor-alpha into human neuroblastoma cells: consequences for cell line behavior and immunomodulatory properties.Semantic proximity Read ↗

A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.